J. Hulthe et al., ANTIBODY-TITERS AGAINST OXIDIZED LDL ARE NOT ELEVATED IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, Arteriosclerosis, thrombosis, and vascular biology, 18(8), 1998, pp. 1203-1211
Antibodies against oxidized low density lipoproteins (Ox-LDLs) have be
en proposed to be independent predictors of atherosclerosis developmen
t. The main aims of the current study were to (1) compare antibody tit
ers to Ox-LDL in patients with heterozygous familial hypercholesterole
mia (n=51) with those in matched controls (n=45) and (2) analyze wheth
er the antibody titers were related to the extent of atherosclerosis,
as assessed cross-sectionally and prospectively by ultrasonography in
the 2 study groups. Antibody titers were determined with a solid-phase
ELISA, and plates were coated with the antigens Ox-LDL or malondialde
hyde-treated LDL (MDA-LDL) as well as with the postcoat only (5% dry m
ilk powder). Antibody titers were expressed as absorbance [(value in p
atient serum minus that in postcoat) divided by (Internal Standard Ser
um minus postcoat)]. There were no significant differences in antibody
titers against Ox-LDL or MDA-LDL between the group of patients with f
amilial hypercholesterolemia and the controls. In cross-sectional comp
arisons, no significant associations were observed between the intima-
media thickness of the carotid or femoral arteries and antibody titers
against Ox-LDL or between plaque occurrence and these titers. Patient
s with a history of myocardial infarction had significantly lower IgM
titers against Ox-LDL compared with patients without a history of myoc
ardial infarction and with controls. In conclusion, mean values for an
tibody titers against Ox-LDL were not increased in the patient group c
ompared with a healthy control group, and no positive, significant rel
ationship was observed between antibody titers and the extent of ather
osclerosis, as measured by ultrasound, in the carotid or femoral arter
ies. Taken together, these findings indicate that the relationship bet
ween the autoimmune response to Ox-LDL and the extent of atheroscleros
is is more complex than previously anticipated.